Industry News
Radiotherapy halves deaths from prostate cancer 15 years after diagnosis
5/10/2016
A longitudinal Nordic study, comparing the results of hormone (antiandrogen) therapy with or without the addition of local radiotherapy, shows that a combination of treatments halves the risk of...
New research gives deeper understanding of why some breast cancers are hard to treat
5/10/2016
Scientists have unearthed crucial new genetic information about how breast cancer develops and the genetic changes which can be linked to survival, according to a Cancer Research UK-funded study...
Junction opening protein boosts cancer-killing effect of oncolytic virus
5/10/2016
A new study shows that the anti-tumor effect of oncolytic virus therapy is significantly greater in mice when the virus is genetically modified to express a junction opening (JO) protein, which helps...
Gamma-retroviruses preferentially integrate near cancer-associated genes
5/10/2016
Profiling gamma-retrovirus integration sites may be a new tool to identify genes promoting specific cancers.
Modeling and simulation help optimize chemotherapy to combat brain tumor
5/10/2016
St. Jude Children's Research Hospital scientists have used sophisticated pharmacologic modeling and simulation to translate preclinical findings into a successful phase I clinical trial of a...
Scripps Florida scientists pioneer a breakthrough approach to breast cancer treatment
5/09/2016
In a development that could lead to a new generation of drugs to precisely treat a range of diseases, scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first...
BRCA gene mutations associated with increased prostate cancer risk
5/09/2016
Though predominantly known for their increased associations with breast cancer risk, germline mutations in the BRCA1 and BRCA2 genes are also associated with an increased susceptibility to other...
Experimental therapy halts treatment-resistant brain tumors
5/09/2016
Researchers report in the journal Cancer Cell an experimental therapy that in laboratory tests on human cells and mouse models stops aggressive, treatment-resistant and deadly brain cancers called...
Prostate cancer: Testosterone therapy 'does not increase aggressive disease risk'
5/09/2016
A study using Swedish data finds men prescribed testosterone for over a year had no overall rise in prostate cancer risk, and they showed a 50 percent fall in aggressive disease.
What can we learn from zebrafish about human blood disorders?
5/09/2016
Genetic regulation of the various types of blood cells in zebrafish and humans is highly similar, making it relatively easy and cost-effective to perform genetic, chemical, imaging and other...